Cargando…
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer, and its incidence is rapidly increasing in North America and Western Europe as well as South-East Asia. Patients with advanced stage HCC have very poor outcomes; therefore, the discovery of new innovative approaches is urgently needed....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543238/ https://www.ncbi.nlm.nih.gov/pubmed/31171886 http://dx.doi.org/10.3748/wjg.v25.i20.2416 |